Literature DB >> 17218418

Adrenomedullin-2, a novel calcitonin/calcitonin-gene-related peptide family peptide, relaxes rat mesenteric artery: influence of pregnancy.

Madhu Chauhan1, Gracious R Ross, Uma Yallampalli, Chandra Yallampalli.   

Abstract

Adrenomedullin-2 (ADM2), a novel calcitonin/calcitonin-gene-related peptide family peptide, is reported to reduce blood pressure in both normal and hypertensive rats. This study demonstrates gestational regulation of circulatory ADM2 in rat plasma. ADM2 dose-dependently reduces the mean arterial pressure in rats, whereas the hypotensive effect of ADM2 is significantly higher during pregnancy. In addition, immunoreactive ADM2 protein is distributed in perivascular fibers of rat mesenteric artery, and levels of pre-pro-ADM2 are significantly (P<0.05) elevated in pregnant compared with nonpregnant rat mesenteric artery. Furthermore, incubation of endothelium intact arterial tissue from pregnant rats with ADM217-47, an ADM2 antagonist, shifted the dose-dependent relaxation curve to the right in wire myography. Inhibition of soluble guanylate cyclase with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (10 microM) or endothelial nitric oxide synthase with N-nitro-L-arginine methyl ester (100 microM) reduced the relaxation of mesenteric artery induced by ADM2. Inhibition of adenylate cyclase with SQ22536 (10 microM) or protein kinase A with the Rp diastereomer of cyclic adenosine 3',5'-phosphorothioate (10 microM) also reduced the maximal relaxation responses induced by ADM2. Blockade of calcium-activated potassium channels with tetraethylammonium chloride (1 mM) inhibited the ADM2-induced relaxation, whereas blockade of ATP-sensitive potassium channels with glybenclamide (10 microM) did not affect the relaxation response. Hence the mechanism of ADM2-induced vasorelaxation is nitric oxide and receptor mediated and cGMP and cAMP dependent and occurs through activation of calcium-activated potassium channels. In conclusion, rat pregnancy is associated with increased levels of circulatory and vascular tissue ADM2 with concomitant increase in the in vivo hypotensive effect of ADM2 and vascular reactivity of mesenteric artery to ADM2, thus suggesting involvement of ADM2 in vascular adaptations during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218418     DOI: 10.1210/en.2006-1105

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Adrenomedullin2 (ADM2)/intermedin (IMD) in rat ovary: changes in estrous cycle and pregnancy and its role in ovulation and steroidogenesis.

Authors:  Madhu Chauhan; Meena Balakrishnan; Chellakkan S Blesson; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2014-11-13       Impact factor: 4.285

Review 2.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

3.  Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts.

Authors:  Madhu Chauhan; Meena Balakrishnan; Uma Yallampalli; Janice Endsley; Gary D V Hankins; Regan Theiler; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2011-08-03       Impact factor: 4.285

4.  Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers.

Authors:  M Aslam; U Pfeil; D Gündüz; A Rafiq; W Kummer; H M Piper; T Noll
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Pregnancy Increases Relaxation in Human Omental Arteries to the CGRP Family of Peptides.

Authors:  Yuanlin Dong; Ancizar Betancourt; Madhu Chauhan; Meena Balakrishnan; Fernando Lugo; Matthew L Anderson; Jimmy Espinoza; Karin Fox; Michael Belfort; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2015-10-28       Impact factor: 4.285

6.  Adrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia.

Authors:  Madhu Chauhan; Meena Balakrishnan; Alex Vidaeff; Uma Yallampalli; Fernando Lugo; Karin Fox; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2016-09-01       Impact factor: 5.958

7.  Potential role of intermedin/adrenomedullin 2 in early embryonic development in rats.

Authors:  Madhu Chauhan; Rebekah Elkins; Meena Balakrishnan; Chandra Yallampalli
Journal:  Regul Pept       Date:  2011-06-02

Review 8.  The pharmacology of adrenomedullin 2/intermedin.

Authors:  Yanguo Hong; Debbie L Hay; Remi Quirion; David R Poyner
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Intermedin/adrenomedullin 2 is associated with implantation and placentation via trophoblast invasion in human pregnancy.

Authors:  Dara Havemann; Meena Balakrishnan; Mostafa Borahay; Regan Theiler; Kristofer Jennings; Janice Endsley; John Phelps; Gary D V Hankins; Chandra Yallampalli; Madhu Chauhan
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

10.  Expression of adrenomedullin 2 (ADM2)/intermedin (IMD) in human placenta: role in trophoblast invasion and migration.

Authors:  Madhu Chauhan; Uma Yallampalli; Yuan-Lin Dong; Gary D V Hankins; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2009-06-17       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.